Company intelligence / Profile preview

Laboratorio Elea Phoenix S.A.

Buenos Aires / Los Polvorines*, Buenos Aires Province / CABA*, Argentinaelea.com ↗

Ownership: Private
Employees: ~1000
Development stage: Commercial

Overview

Laboratorio Elea Phoenix is a leading Argentine pharmaceutical company with over eight decades of experience. It develops, manufactures, and markets a wide range of medicines across multiple specialties. The company has approved products in Argentina and other countries, with ongoing clinical development in oncology, infectious diseases, women’s health, cardiology, neurology, and more. Its pipeline includes both innovative drugs and vaccines at various stages up to commercial approval.

Therapeutic areas: CardiovascularWomen's HealthOncologyNeurologyInfectious Diseases
Modalities: Small moleculesVaccinesMonoclonal antibodies (mAbs)
Industry: Biotech

Drug pipeline

1 asset

Nearlea

Unknown

Beyond the preview

Go deeper on Laboratorio Elea Phoenix S.A..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laboratorio Elea Phoenix S.A..

Explore the full profile